{
    "title": "Astrazeneca set for tough year amid fierce competition from generic rivals",
    "url": "https://www.dailymail.co.uk/money/markets/article-2271565/Astrazeneca-set-tough-year-amid-fierce-competition-generic-rivals.html",
    "date": "2013-01-31",
    "keywords": [
        "soriot",
        "year",
        "cent",
        "patent",
        "astrazeneca",
        "competition",
        "executive",
        "company",
        "slump",
        "expiry",
        "set",
        "mail",
        "gmt",
        "view",
        "warning",
        "companys",
        "trading",
        "impact",
        "seroquel",
        "saw",
        "fall",
        "astrazenecas",
        "boss",
        "firm",
        "innovation",
        "growth",
        "pipeline",
        "performance",
        "period",
        "market",
        "job",
        "fuller",
        "strategy",
        "review",
        "march",
        "time",
        "drugmaker",
        "protection",
        "biggestselling",
        "austerity",
        "faller",
        "ftse",
        "index",
        "city",
        "broker",
        "panmure",
        "gordon",
        "update",
        "analyst",
        "drug",
        "guidance",
        "comfort",
        "challenge",
        "cushion",
        "revenue",
        "consumer",
        "healthcare",
        "roche",
        "share",
        "buyback",
        "programme",
        "kidney",
        "bolton",
        "astra",
        "downturn"
    ],
    "category": [
        "money",
        "markets"
    ]
}